OpenLegislation

Article 15 F1

United Kingdom

Original text. Later amendments are not shown.

Without prejudice to measures adopted in accordance with Article 26(3), the granting of the export authorisation shall be refused if:

  1. (a)

    details supplied in accordance with Article 13(1) are incomplete;

  2. (b)

    there are reasonable grounds for suspecting that the details supplied in accordance with Article 13(1) are false or incorrect;

  3. (c)

    in the cases referred to in Article 17, it is established that the import of the scheduled substances has not been authorised by the competent authorities of the country of destination F2or Northern Ireland, or

  4. (d)

    there are reasonable grounds for suspecting that the substances in question are intended for the illicit manufacture of narcotic drugs or psychotropic substances.

Annotations

Textual amendments

F1

Regulation revoked (N.I.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), reg. 1(1), Sch.

F2

Words in Art. 15(c) inserted (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 6(13)

Notes on the whole EU Regulation

Textual amendments

F2

Substituted by Regulation (EU) No 1259/2013 of the European Parliament and of the Council of 20 November 2013 amending Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third countries in drug precursors.